Literature DB >> 617926

Antibody dependent and spontaneous lymphocyte mediated cytotoxicity in normal subjects, patients with SLE, and malignancies.

I Láng, M Benczur, M Varga, P Gergely, G Petrányi.   

Abstract

Antibody dependent and spontaneous lymphocyte mediated cytotoxicity was studied in healthy subjects and patients with systemic lupus erythematosus and metastatic tumours. The purified peripheral blood lymphocytes of healthy subjects exerted a similar cytotoxic activity on allogeneic K-562 and xenogeneic chicken erythrocyte targets in the antibody dependent and spontaneous lymphocyte mediated cytotoxicity tests. There was a stronger correlation between the cytotoxicity measured in the two allogeneic assays than between allogeneic and xenogeneic tests. Allogeneic systems using K-562 targets were more sensitive to changes in cytotoxic activity in systemic lupus erythematosus and metastatic tumours than was the xenogeneic chicken erythrocyte assay.

Entities:  

Mesh:

Year:  1977        PMID: 617926

Source DB:  PubMed          Journal:  Acta Med Acad Sci Hung        ISSN: 0001-5989


  4 in total

1.  Depressed lectin-dependent cell-mediated cytotoxicity against adherent HEP-2 cells in patients with carcinoma of the uterine cervix.

Authors:  A Perl; R Gonzalez-Cabello; I Láng; P Somos; P Gergely
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

2.  The effect of E-N-L-trimethyllysine (TML) on the humoral and cellular immune response.

Authors:  G Elek; I Láng; B Szende; K Lapis
Journal:  Agents Actions       Date:  1982-10

3.  Inhibition of natural killer cell activity by serum from patients with systemic lupus erythematosus: roles of disease activity and serum interferon.

Authors:  S R Ytterberg; T J Schnitzer
Journal:  Ann Rheum Dis       Date:  1984-06       Impact factor: 19.103

4.  Retroperitoneal plasmocytic giant lymph node hyperplasia.

Authors:  I Láng; E Magyarosy; L Kopper; K Lapis; G Petrányi
Journal:  J R Soc Med       Date:  1984-06       Impact factor: 18.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.